Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 1b, Multicenter, Open-label, Staggered-dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of CC-90001 for 3 Months in Patients Wi
Brief Summary: Participation in the study will last for 3months, with a 1 month screening phase.